000806 On Other Exchanges
Symbol
Exchange
Shenzhen

galaxy biomedical investme-a (000806) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GALAXY BIOMEDICAL INVESTME-A (000806)
\

Related News

No related news articles were found.

galaxy biomedical investme-a (000806) Related Businessweek News

No Related Businessweek News Found

galaxy biomedical investme-a (000806) Details

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China. The company produces and sells various transformer products, such as power, rectifier, and special transformers for use in metal smelting, electrochemistry, and power grid companies; and manufactures and sells electronic components, including displacement sensors, brake resistance boxes, radio frequency components, resistors, potentiometers, and others for use in military and civilian products. It also offers animal products, and monoclonal antibody and targeted drugs, as well as drugs for the treatment of cancer and other diseases; laboratory equipment; and CRO, CAR-T technology and stem cell technology research and development, malignant cancer immune cell technology, and genetic testing services. The company also exports its products. The company was formerly known as Beihai Yinhe Industry Investment Co., Ltd. and changed its name to Galaxy Biomedical Investment Co., Ltd. in October 2015. Galaxy Biomedical Investment Co., Ltd. was founded in 1993 and is based in Beihai, China.

2,189 Employees
Last Reported Date: 04/27/19
Founded in 1993

galaxy biomedical investme-a (000806) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

galaxy biomedical investme-a
Galaxy Biomedical Investment Co., Ltd.(SZSE:000806) dropped from Shenzhen Stock Exchange Component Index

Galaxy Biomedical Investment Co., Ltd. has been removed from Shenzhen Stock Exchange Component Index .

Galaxy Biomedical Investment Co., Ltd., Annual General Meeting, May 17, 2019

Galaxy Biomedical Investment Co., Ltd., Annual General Meeting, May 17, 2019, at 14:00 China Standard Time. Agenda: To consider the 2018 annual report and its summary; to consider the 2018 work report of the board of directors; to consider the 2018 work report of the supervisory committee; to consider the 2018 annual accounts; to consider the 2018 profit distribution plan; to consider the appointment of 2019 financial audit firm and internal control audit firm; to consider the 2019 provision of guarantee for controlled subsidiaries; to consider the change of non-employee supervisors; to consider the shareholder return plan for the next three years from 2019 to 2021; and to consider the 2018 provision for assets impairment and write-off of assets.

Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019

Galaxy Biomedical Investment Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was CNY 160.729 million compared to CNY 188.083 million a year ago. Operating loss was CNY 11.907 million compared to CNY 19.692 million a year ago. Net loss was CNY 12.415 million compared to CNY 20.482 million a year ago. Basic loss per share from continuing operations was CNY 0.0113 compared to CNY 0.0186 a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

000806 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000806.
View Industry Companies
 

Industry Analysis

000806

Industry Average

Valuation 000806 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GALAXY BIOMEDICAL INVESTME-A, please visit www.g-biomed.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.